Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
Clinical trial NCT05065957 · RECRUITING
Trial details
- NCT number
- NCT05065957
- Sponsor
- InnoPharmax Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-29
- Primary completion
- 2026-07-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.